|
This week we would like
you to answer the question:
According to the current guidelines, which of the following statements regarding
the treatment of diabetes and cardiovascular disease is least accurate?
1. Metformin is first-line
therapy for overweight patients with type 2 diabetes
2. Rosiglitazone may
prevent the progression of impaired glucose tolerance to diabetes
3. Beta-blockers should
be avoided among patients with cardiovascular disease because of a risk of
masking hypoglycemic symptoms
4. Aspirin may be
used at similar dosages regardless of the presence of diabetes among patients
with coronary heart disease
|